Home › NDC Lookup › RxCUI directory › RxCUI 808917

Fosfomycin 3000 MG Granules for Oral Solution — RxCUI 808917

Name: Fosfomycin 3000 MG Granules for Oral Solution (RxCUI 808917)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 808917 Semantic clinical drug · SCD ● Current RxNorm concept 10 FDA products 12 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI808917

Official nameFosfomycin 3000 MG Granules for Oral Solution

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asfosfomycin 3 GM Granules for Oral Solution; fosfomycin (as fosfomycin tromethamine) 3000 MG Granules for Oral Solution

FDA products mapped10

Package NDCs mapped12

Reported Medicaid activity (SDUD)23,298 prescriptions · 44 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Fosfomycin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

That depends on the type of infection and which form of fosfomycin you're being prescribed. The oral powder or solution (brands like Monurol or Fosfomycin Tromethamine) is a single...
What kind of UTI is fosfomycin used for — and is it right for me?
You pour the entire contents of the single sachet into about half a cup (3–4 ounces) of cool water, stir until it dissolves completely, and drink it right away. Don't use hot water...
How do I take the oral powder — do I need water or food?

📖 Read our full Fosfomycin guide →

🕸️ Concept Web — How Fosfomycin 3000 MG Granules for Oral Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Fosfomycin 3000 MG Granules for Oral Solution RxCUI 808917 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Fosfomycin 4550 IN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Fosfomycin Granules for Oral Solution 2697784 SCDF
- Fosfomycin Granule Product 2697783 SCDG
- Fosfomycin Oral Product 1162672 SCDG
- Granules for Oral Solution 1540453 DF
- Granule Product 1294708 DFG
- Oral Product 1151131 DFG
Clinical & branded drugs 1

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Fosfomycin 3000 MG 1870348 SCDC

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Fosfomycin 3000 MG SCDC · 1870348
Fosfomycin Granules for Oral Solution SCDF · 2697784
Fosfomycin Granule Product SCDG · 2697783
Fosfomycin Oral Product SCDG · 1162672

📦 FDA Products & Package NDCs

10 products · 12 package NDCs

12 package NDCs map to RxCUI 808917 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
50090-5826-00	1 DOSE PACK in 1 CARTON (50090-5826-0) / 1 POWDER in 1 DOSE...	FOSFOMYCIN TROMETHAMINE	A-S Medication Solutions	2021-10-26
50090-6130-00	1 PACKET in 1 CARTON (50090-6130-0) / 1 GRANULE, FOR SOLUTI...	Fosfomycin Tromethamine	A-S Medication Solutions	2022-10-03
59651-0651-03	1 PACKET in 1 CARTON (59651-651-03) / 1 GRANULE, FOR SOLUTI...	Fosfomycin tromethamine	Aurobindo Pharma Limited	2025-11-14
60219-3955-01	1 PACKET in 1 CARTON (60219-3955-1) / 1 GRANULE, FOR SOLUTI...	Fosfomycin Tromethamine	Amneal Pharmaceuticals NY LLC	2024-04-02
67877-0749-57	1 PACKET in 1 CARTON (67877-749-57) / 1 GRANULE, FOR SOLUTI...	Fosfomycin Tromethamine	Ascend Laboratories, LLC	2021-10-22
68094-0064-20	1 PACKET in 1 CARTON (68094-064-20) / 1 GRANULE in 1 PACKET...	Fosfomycin Tromethamine	Precision Dose, Inc.	2026-02-15
69097-0579-67	1 DOSE PACK in 1 CARTON (69097-579-67) / 1 GRANULE, FOR SOL...	FOSFOMYCIN TROMETHAMINE	Cipla USA Inc.	2022-01-26
70700-0268-94	1 DOSE PACK in 1 CARTON (70700-268-94) / 1 POWDER in 1 DOSE...	FOSFOMYCIN TROMETHAMINE	XIROMED LLC	2020-10-06
70700-0268-99	1 POWDER in 1 PACKET (70700-268-99)	FOSFOMYCIN TROMETHAMINE	XIROMED LLC	2020-10-06
73289-0067-01	1 GRANULE, FOR SOLUTION in 1 PACKET (73289-0067-1)	Fosfomycin Tromethamine	Aucta Pharmaceuticals, Inc.	2026-04-09
73289-0067-02	1 DOSE PACK in 1 CARTON (73289-0067-2) / 1 GRANULE, FOR SOL...	Fosfomycin Tromethamine	Aucta Pharmaceuticals, Inc.	2026-04-09
81033-0024-11	1 PACKET in 1 CARTON (81033-024-11) / 1 GRANULE, FOR SOLUTI...	Fosfomycin Tromethamine	Kesin Pharma Corporation	2025-10-01

Observed labelers: A-S Medication Solutions (2) · Aucta Pharmaceuticals, Inc. (2) · XIROMED LLC (2) · Amneal Pharmaceuticals NY LLC (1) · Ascend Laboratories, LLC (1) · Aurobindo Pharma Limited (1) · +3 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.